Dr. Ronald L. Renard, MD

Dr. Renard practices at Essentia Health-Duluth Clinic 1st Street in Duluth, Minnesota.

Dr. Renard's NPI, 1497792436, was assigned on May 31, 2006. Dr. Renard graduated from Creighton University School of Medicine - Omaha in 1976. Dr. Renard holds California license G36415.

Dr. Renard's primary practice is Essentia Health-Duluth Clinic 1st Street, at 420 E. 1st St., Duluth, MN 55805. The practice phone is (218) 786-1019.

Dr. Renard's primary practice is Essentia Health-Duluth Clinic 1st Street in Duluth, Minnesota. Dr. Renard is also affiliated with Essentia Health-Duluth (Miller-Dwan, Building D). The medical group on file is Essentia Health-Duluth Clinic. Dmand AI also links Dr. Renard to 2 more medical groups and 1 physician office, each named with a free account. Dr. Renard's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renard practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Renard's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Renard is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Renard's licenses on file in 4 states: California, Minnesota, Colorado and Maryland.

Dmand AI lists chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Renard treats.

CMS data shows 11 Medicare services from Dr. Renard across 1 procedure code in 2024, all of them office visits, for 21 Medicare patients. Medicare paid $547 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Renard in 2024. 52% of them have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Renard's median patient age at 60, with 62% women.

In 2024, Dr. Renard wrote 83 Medicare Part D claims for 35 patients. 72% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $159 in total drug cost. In 2022, CMS named 64 claims across 4 drugs.

CMS Open Payments shows 252 general payments to Dr. Renard from 21 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 43% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $2,967.

Dmand AI lists 3 awards for Dr. Renard, most recently CMS Stage 1 EHR in 2013.

Dr. Renard graduated from Creighton University School of Medicine - Omaha in 1976. Dr. Renard is a member of AAAAI.

Dr. Renard is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.